Capital Stock

6 Months Ended

Dec. 31, 2025

Equity [Abstract]

Capital Stock

Note 5. Capital Stock

Authorized Capital

Authorized capital stock consists of 200,000,000 common shares with par value of $0.01 per common share as of December 31, 2025 (June 30, 2025 – 200,000,000 common shares with par value $0.01 per common share).

For the three months ended December 31, 2025, the Company issued 707,355 shares of common stock from its ATM program for net proceeds of $818,545 and issued 346,010 shares of common stock for payment of interest accrued on its outstanding Royalty Convertible Debenture (Note 6) with a fair value of $383,333.

For the three months ended December 31, 2024, the Company issued 137,134 shares of common stock from its ATM program for net proceeds of $57,870 and issued 1,226,529 shares of common stock for payment of interest accrued (Note 6) with a fair value of $383,334.

For the six months ended December 31, 2025, the Company issued 2,853,916 shares of common stock from its ATM program for net proceeds of $2,714,477 and issued 712,062 shares of common stock for payment of interest accrued on its outstanding Royalty Convertible Debenture (Note 6) with a fair value of $766,666.

For the six months ended December 31, 2024, the Company issued 252,052 shares of common stock from its ATM program for net proceeds of $104,228 and issued 2,125,417 shares of common stock for payment of interest accrued on its outstanding Royalty Convertible Debenture (Note 6) with a fair value of $776,668.

Stock Options, Restricted Stock Units and Stock Based Compensation

Paramount’s 2015 and 2016 Stock Incentive and Compensation Plans, which are stockholder-approved, permits the grant of stock options, restricted stock units and stock to its employees and directors for up to 7.5 million shares of common stock.

Total stock based compensation for the three months ended December 31, 2025 and 2024 were $158,360 and $60,451, respectively.

Total stock-based compensation for the six months ended December 31, 2025 and 2024 were $180,528 and $122,656, respectively.

Restricted Stock

During the three and six months ended December 31, 2025, the Company granted and issued 70,000 restricted shares of common stock under its equity compensation plan with a fair value of $84,000.

Stock Options

Stock option awards are generally granted with an exercise price equal to the market price of Paramount’s stock at the date of grant and have contractual lives of 5 years. To better align the interests of its key executives, employees and directors, with those of its shareholders, a significant portion of those share option awards will vest contingent upon meeting certain stock price appreciation performance goals and other performance conditions. Option and share awards provide for accelerated vesting if there is a change in control of the Company (as defined in the Stock Incentive and Compensation Plans).

For the three and six months ended December 31, 2025 and 2024, the Company did not grant any stock options.

A summary of stock option activity under the Stock Incentive and Compensation Plans as of December 31, 2025 is presented below:

Options	Options			Weighted Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at June 30, 2024		1,405,000		$	1.05		1.06	$	—
Granted		—			—		—		—
Exercised		—			—		—		—
Forfeited or expired		(640,000	)		1.00		—		—
Outstanding at June 30, 2025		765,000		$	1.09		0.54	$	650
Granted		—			—		—		—
Exercised		(485,000	)		1.12		—		—
Forfeited or expired		(230,000	)		1.15		—		—
Outstanding at December 31, 2025		50,000		$	0.60		1.49	$	33,000
Exercisable at December 31, 2025		50,000		$	0.60		1.49	$	33,000

A summary of the status of Paramount’s non-vested options at December 31, 2025 is presented below:

Non-vested Options	Options			Weighted- Average Grant- Date Fair Value
Non-vested at June 30, 2024		458,336		$	0.47
Granted		—			—
Vested		(50,000	)		0.56
Forfeited or expired		(247,500	)		0.39
Non-vested at June 30, 2025		160,836		$	0.57
Granted		—			—
Vested		(125,000	)		0.56
Forfeited or expired		(35,836	)		0.62
Non-vested at December 31, 2025		—		$	—

Restricted Stock Units ("RSUs")

RSUs are awards for service and performance which upon vesting and settlement entitle the recipient to receive one common share of the Company's Common Stock for no additional consideration, for each RSU held.

During the three months ended December 31, 2025 and 2024, the Company granted 539,400 and nil RSUs, respectively.

For the six months ended December 31, 2025 and 2024, the Company granted 539,400 and nil RSUs, respectively.

For the three months ended December 31, 2025, share-based compensation expenses related to service condition RSUs and performance condition RSUs was $20,146 and $54,215, respectively (2024 - $32,828 and $26,425).

For the six months ended December 31, 2025, share-based compensation expenses related to service condition RSUs and performance condition RSUs was $31,758 and $64,771, respectively (2024 -$65,656 and $54,603).

A summary of RSUs activity is summarized as follows:

Restricted Share Unit Activity	Outstanding RSUs			Weighted average grant date fair value
Outstanding at June 30, 2024		1,725,000		$	0.31
Granted		1,058,000			0.35
Vested		(1,713,000	)		0.35
Forfeited		(225,000	)		0.22
Outstanding at June 30, 2025		845,000		$	0.37
Granted		539,400			1.14
Vested		(250,000	)		0.47
Forfeited		—			—
Outstanding at December 31, 2025		1,134,400		$	0.71

As of December 31, 2025, there was approximately $595,751 of unamortized stock-based compensation expense related to outstanding RSUs. This expense is expected to be recognized over the remaining weighted-average vesting periods of approximately 1.35 years.